Servier Malaysia

Servier Malaysia company information, Employees & Contact Information

Explore related pages

Related company profiles:

Servier is a global pharmaceutical group governed by a Foundation. Relying on a solid geographical presence and revenue of €4.7 billion in 2020 achieved in 150 countries, Servier employs 22,500 people worldwide. Servier is an independent group that invests over 20% of its brand-name revenue in Research and Development every year. To accelerate therapeutic innovation for the benefit of patients, the Group is committed to open and collaborative innovation with academic partners, pharmaceutical groups, and biotech companies. It also integrates the patient’s voice at the heart of its activities, from research to support beyond the pill. A leader in cardiology, the ambition of the Servier Group is to become a renowned and innovative player in oncology. Its growth is based on a sustained commitment to cardiovascular and metabolic diseases, oncology, neuroscience and immuno-inflammatory diseases. To promote access to healthcare for all, the Servier Group also offers a range of quality generic drugs covering most pathologies. -- To report a suspected adverse event with a Servier drug, please visit servier.com

Company Details

Employees
70
Founded
-
Address
Level 25-02, Imazium, No.8,jalan Ss21/37,damansara Uptown,malaysia
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Petaling Jaya, Selangor
Looking for a particular Servier Malaysia employee's phone or email?

Servier Malaysia Questions

News

Blue March 2025: More determined than ever to combat colorectal cancer - Servier

Blue March 2025: More determined than ever to combat colorectal cancer Servier

Understanding AI’s impact on the pharmaceutical industry in five questions - Servier

Understanding AI’s impact on the pharmaceutical industry in five questions Servier

Tackling Inequities in Childhood Cancer Through Unique Global Collaboration - Servier

Tackling Inequities in Childhood Cancer Through Unique Global Collaboration Servier

AI to help industry reduce environmental impact - Servier

AI to help industry reduce environmental impact Servier

Finally, a day dedicated to therapeutic adherence! - Servier

Finally, a day dedicated to therapeutic adherence! Servier

Integrated annual report 2023/2024 - Servier

Integrated annual report 2023/2024 Servier

Servier takes on therapeutic adherence! - Servier

Servier takes on therapeutic adherence! Servier

Servier delivers strong results in 2023/2024 and outpaces its trajectory to 2030 - Servier

Servier delivers strong results in 2023/2024 and outpaces its trajectory to 2030 Servier

Servier and IDEAYA Biosciences Partner to Bring Darovasertib, a Promising Uveal Melanoma Treatment, to Patients Worldwide - Yahoo Finance

Servier and IDEAYA Biosciences Partner to Bring Darovasertib, a Promising Uveal Melanoma Treatment, to Patients Worldwide Yahoo Finance

Therapeutic efficacy - Servier

Therapeutic efficacy Servier

Servier appoints David K. Lee to Executive Committee - Servier

Servier appoints David K. Lee to Executive Committee Servier

Servier and Google Cloud Expand Partnership on using data and AI - Servier

Servier and Google Cloud Expand Partnership on using data and AI Servier

Bio-S: a unique facility in Europe for the clinical manufacture of new biodrugs - Servier

Bio-S: a unique facility in Europe for the clinical manufacture of new biodrugs Servier

GreenScore: A User-Friendly Tool for Assessing the Sustainability of Chemical Processes - ACS Publications

GreenScore: A User-Friendly Tool for Assessing the Sustainability of Chemical Processes ACS Publications

Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals - Oncodaily

Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals Oncodaily

Servier and Black Diamond Therapeutics Announce Global - GlobeNewswire

Servier and Black Diamond Therapeutics Announce Global GlobeNewswire

Pancreatic cancer: Often diagnosed too late - Servier

Pancreatic cancer: Often diagnosed too late Servier

7 start-ups hosted - Servier

7 start-ups hosted Servier

Learn more about our development portfolio - Servier

Learn more about our development portfolio Servier

Our commitment to oncology - Servier

Our commitment to oncology Servier

Servier Executive Committee appointments - Servier

Servier Executive Committee appointments Servier

See our bases throughout the world - Servier

See our bases throughout the world Servier

The Group in figures - Servier

The Group in figures Servier

Fostering a healthy environment - Servier

Fostering a healthy environment Servier

Pancreatic Cancer: Aitia and Servier will collaborate - Servier

Pancreatic Cancer: Aitia and Servier will collaborate Servier

The age of augmented research - Servier

The age of augmented research Servier

Digital tech as a super power to serve patient needs - Servier

Digital tech as a super power to serve patient needs Servier

Neuroscience: new research partnership for Servier - Servier

Neuroscience: new research partnership for Servier Servier

Parkinson’s Disease: New Collaboration with Aitia - Servier

Parkinson’s Disease: New Collaboration with Aitia Servier

Boston-Cambridge: a world-renowned innovation hub - Servier

Boston-Cambridge: a world-renowned innovation hub Servier

Gastric cancer: a disease of the stomach - Servier

Gastric cancer: a disease of the stomach Servier

Increased patient adherence thanks to health care professionals - Servier

Increased patient adherence thanks to health care professionals Servier

Celebrating SRIMC: A Decade of Innovation in Chemistry - Servier

Celebrating SRIMC: A Decade of Innovation in Chemistry Servier

Our ambition for 2030 - Servier

Our ambition for 2030 Servier

All taking action to support the fight against gastric & pancreatic cancers - Servier

All taking action to support the fight against gastric & pancreatic cancers Servier

Insights, the magazine that deciphers the pharmaceutical industry - Servier

Insights, the magazine that deciphers the pharmaceutical industry Servier

Cardiology: Gaining perspective on therapeutic adherence - Servier

Cardiology: Gaining perspective on therapeutic adherence Servier

“The Patient Side of the Story”: Hear from Estelle and Veerle - Servier

“The Patient Side of the Story”: Hear from Estelle and Veerle Servier

All our latest news - Servier

All our latest news Servier

Servier at ASH meeting to present new data in hematology research - Servier

Servier at ASH meeting to present new data in hematology research Servier

Patient associations’ perception of pharmaceutical companies: Servier is making progress! - Servier

Patient associations’ perception of pharmaceutical companies: Servier is making progress! Servier

Nicolas Lévy joins Servier as Chief Scientist Rare Diseases - Servier

Nicolas Lévy joins Servier as Chief Scientist Rare Diseases Servier

Nicolas Garnier joins Servier as Chief Patient Officer - Servier

Nicolas Garnier joins Servier as Chief Patient Officer Servier

The Servier Saclay R&D Patient Board: A podcast series - Servier

The Servier Saclay R&D Patient Board: A podcast series Servier

“Patient’s Side of the Story”: All episodes online! - Servier

“Patient’s Side of the Story”: All episodes online! Servier

Servier is Top Employer Europe for the 3rd consecutive year! - Servier

Servier is Top Employer Europe for the 3rd consecutive year! Servier

Servier reveals a new visual identity - Servier

Servier reveals a new visual identity Servier

She Is Servier program launches in Asia - Servier

She Is Servier program launches in Asia Servier

PRISM BioLab, a new partner for Servier in immuno-oncology - Servier

PRISM BioLab, a new partner for Servier in immuno-oncology Servier

Changes to the Executive Committee of Servier Group - Servier

Changes to the Executive Committee of Servier Group Servier

New managerial practices to foster employee engagement - Servier

New managerial practices to foster employee engagement Servier

Appointment of Walid S. Kamoun, PhD. MSc., Global Head of Servier R&D Oncology - Servier

Appointment of Walid S. Kamoun, PhD. MSc., Global Head of Servier R&D Oncology Servier

The Research and Development Institute in Paris-Saclay - Servier

The Research and Development Institute in Paris-Saclay Servier

First review for PROMETCO, Servier’s real-world study - Servier

First review for PROMETCO, Servier’s real-world study Servier

Immuno-oncology: Dosing of first patient in phase 1/2 trial - Servier

Immuno-oncology: Dosing of first patient in phase 1/2 trial Servier

Servier launches new venous disease awareness campaign - Servier

Servier launches new venous disease awareness campaign Servier

Pancreatic cancer: a new treatment available for Argentine patients - Servier

Pancreatic cancer: a new treatment available for Argentine patients Servier

Colorectal cancer: discover our partnership with Celsius Therapeutics in video - Servier

Colorectal cancer: discover our partnership with Celsius Therapeutics in video Servier

Servier on the front line of cardiovascular disease prevention and therapeutic adherence - Servier

Servier on the front line of cardiovascular disease prevention and therapeutic adherence Servier

Discover in video the commitment of Servier in oncology - Servier

Discover in video the commitment of Servier in oncology Servier

World Cancer Day: a top priority for Servier - Servier

World Cancer Day: a top priority for Servier Servier

World Anti-Counterfeiting Day: on the front line for patient safety - Servier

World Anti-Counterfeiting Day: on the front line for patient safety Servier

Servier co-sponsor of the Paris-Saclay SPRING - Servier

Servier co-sponsor of the Paris-Saclay SPRING Servier

Servier receives European Commission approval of Tibsovo® (ivosidenib tablets) in IDH1-mutated Acute Myeloid Leukemia and IDH1-mutated Cholangiocarcinoma - PR Newswire

Servier receives European Commission approval of Tibsovo® (ivosidenib tablets) in IDH1-mutated Acute Myeloid Leukemia and IDH1-mutated Cholangiocarcinoma PR Newswire

Tutorial Videos - Servier Medical Art

Tutorial Videos Servier Medical Art

World Diabetes Day: promoting prevention, treatment, and care of diabetes - Servier

World Diabetes Day: promoting prevention, treatment, and care of diabetes Servier

White blood cells Archives - Servier Medical Art

White blood cells Archives Servier Medical Art

Allogene Therapeutics, with Collaborator Servier, Reports Positive Results from its Phase 1 ALPHA Study of ALLO-501 in Relapsed/Refractory Non-Hodgkin Lymphoma at the American Society of Clinical Oncology Annual Meeting - Allogene

Allogene Therapeutics, with Collaborator Servier, Reports Positive Results from its Phase 1 ALPHA Study of ALLO-501 in Relapsed/Refractory Non-Hodgkin Lymphoma at the American Society of Clinical Oncology Annual Meeting Allogene

Servier to Acquire Agios Pharmaceuticals' Oncology Business - PR Newswire

Servier to Acquire Agios Pharmaceuticals' Oncology Business PR Newswire

Receptors and Channels - Servier Medical Art

Receptors and Channels Servier Medical Art

Drugs and Treatments - Servier Medical Art

Drugs and Treatments Servier Medical Art

Servier unveils its 2030 ambition and reveals a new visual identity - PR Newswire UK

Servier unveils its 2030 ambition and reveals a new visual identity PR Newswire UK

Top Servier Malaysia Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant